Novo Nordisk is celebrating 90 years of treating diabetes patients with the company's insulin. The company is focused on developing new and better treatments for people with diabetes and is now the world's largest diabetes care company. Novo Nordisk provides therapeutic treatments for an estimated 23 million people with diabetes worldwide and produces approximately 50% of all insulin in the world.
Novo Nordisk's Canadian roots run deep and can be traced back to the University of Toronto, where Sir Frederick Banting and Charles Best first discovered insulin in 1921. In 1923, Nobel-prize winning physiologist Dr. August Krogh was granted permission from Banting and Best to produce insulin in Denmark, founding Nordisk Insulinlaboratorium - the company now known as Novo Nordisk.
Since then, the company has led the industry with many important advances in diabetes treatment including human insulin (1982) and the world's first insulin pen, NovoPen® (1985).
"Ninety years ago, our commitment to helping those living with diabetes began, shaping Novo Nordisk into the world leading diabetes company it is today," said Vince Lamanna, President, Novo Nordisk Canada Inc. "It is important to recognize and celebrate our roots as we move forward, striving for new innovations and advancements that help build a healthy future for Canadians, and people around the world."
In 2002, Novo Nordisk founded the World Diabetes Foundation, which has grown into a leading international funding agency supporting grassroots initiatives in the area of diabetes prevention and care in the developing world. In 2006, Novo Nordisk joined the International Diabetes Federation and the Unite for Diabetes campaign to successfully pass a UN resolution recognizing World Diabetes Day.
More than three million Canadians are living with diabetes, according to the Canadian Diabetes Association. In addition there are more than 25 million people in the US with diabetes, according to the American Diabetes Association.
NOTE:
This article was taken in part from a press release by Novo Nordisk. It is not intended to replace the medical advice of your physician. If you are experiencing any of the symptoms of diabetes, make an appointment with your physician.
Upcoming Events & Information Request
Do you have an upcoming event or information that would interest the Lancaster Diabetic community? If so, please email Jeanne Ruczhak-Eckman at jeanne.eckman@comcast.net.
Subscribe to get free, instant updates on diabetes on Examiner.com
• Are you on Facebook? Follow Jeanne Ruczhak-Eckman.
• Tweet me @jeanne_eckman.
• Feel free to leave comments below
Comments